2-Methoxy-6-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine is an intermediate used to prepare pyridine compounds as modulators of cystic fibrosis transmembrane conductance regulator (CFTR) useful in treatment of CFTR-mediated diseases.